Bipolar Plasma Enucleation of the Prostate (B-TUEP) in Benign Prostate Hypertrophy Treatment: 3-Year Results
| Autor: | Cristina Falavolti, Roberto Giulianelli, Paola Tariciotti, Gabriella Mirabile, Luca Albanesi, Giorgio Rizzo, Maurizio Buscarini, Barbara Cristina Gentile |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Time Factors Adenoma Urology Enucleation Prostatic Hyperplasia 030232 urology & nephrology Lasers Solid-State 03 medical and health sciences 0302 clinical medicine Prostate Humans Medicine Prospective Studies Prospective cohort study Aged Aged 80 and over business.industry Ultrasound Transurethral Resection of Prostate Middle Aged medicine.disease Urinary Bladder Neck Obstruction Treatment Outcome medicine.anatomical_structure 030220 oncology & carcinogenesis Concomitant Quality of Life International Prostate Symptom Score Prostate surgery Laser Therapy Volatilization business Follow-Up Studies |
| Zdroj: | Urology. 107:190-195 |
| ISSN: | 0090-4295 |
| Popis: | To investigate numerous endoscopic techniques that have been described for the treatment of benign prostate enlargement. Plasma-button enucleation of the prostate (B-TUEP) is a successful treatment option because the large surface creates a fast enucleation process, vaporization, and concomitant hemostasis. The aim of this study was to evaluate the efficacy of bipolar button electrode transurethral adenoma enucleation (B-TUEP) in saline solution. The second end point was to determine the change of International Prostate Symptom Score (IPSS), post-void residual urine, International Index of Erectile Function, transrectal ultrasound gland volume evaluation, and prostate-specific antigen.Between July 2011 and March 2012, 50 consecutive patients underwent B-TUEP in our facility, all performed by a single surgeon (R.G.). All patients were preoperatively assessed with maximum urinary flow rate, single-question quality of life assessment, IPSS and the International Index of Erectile Function questionnaires, transrectal ultrasound gland volume evaluation, prostate-specific antigen, and post-void residual urine.We observed a significant improvement at 12, 24, and 36 months in terms of maximum urinary flow rate (22.3 ± 4.74 mL/s, 23.2 ± 0.30 mL/s, and 23.6 ± 1.26 mL/s, respectively, P .01) and quality of life (5.28 ± 0.97, 5.69 ± 0.90, and 5.73 ± 0.87). IPSS and IEEF scores improved significantly (P .05). Gland volume evaluation and post-void residue decreased (P .001). The prostate-specific postoperative antigen levels were 0.76 ± 0.61 ng/mL, 0.7 ± 0.51 ng/mL, and 0.62 ± 0.18 ng/mL, at 12, 24, and 36 months, respectively. Two patients (4%) had persistent bladder outlet obstruction requiring reoperation.After 3-year follow-up, B-TUEP represents an effective, durable, and safe form of surgical intervention. B-TUEP is an alternative treatment for symptomatic benign prostate enlargement. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect